Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Early surgical intervention and a multidisciplinary approach are crucial for managing complex cardio-obstetric patients.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

The letters discussed medical tools, costs, treatment efficacy, and patient care complexities.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

VDR regulation varies by tissue and is crucial for its biological functions.

Balanced vitamin D levels are crucial to delay aging and prevent related diseases.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

MS patients often have skin issues, so regular skin checks are important.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Mouse models help understand alopecia areata and find treatments.

Dermal EZH2 controls skin cell development and hair growth in mice.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Skin biopsies are recommended for confirming alopecia diagnosis due to variability in clinical assessments; the link between vitamin D levels and alopecia is unclear.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Vitamin D receptor helps control hair growth and could be used to treat certain skin tumors.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

Vitamin D receptor may help protect against UV-induced skin cancer.

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

COVID-19 infection may trigger alopecia areata in some patients.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.